Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 2
1993 1
1998 1
2003 1
2004 1
2005 1
2007 2
2008 1
2011 6
2012 3
2013 3
2014 4
2015 4
2016 6
2017 6
2018 6
2019 5
2020 8
2021 7
2022 7
2023 9
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
De-escalation of radiotherapy after primary chemotherapy in cT1-2N1 breast cancer (RAPCHEM; BOOG 2010-03): 5-year follow-up results of a Dutch, prospective, registry study.
de Wild SR, de Munck L, Simons JM, Verloop J, van Dalen T, Elkhuizen PHM, Houben RMA, van Leeuwen AE, Linn SC, Pijnappel RM, Poortmans PMP, Strobbe LJA, Wesseling J, Voogd AC, Boersma LJ. de Wild SR, et al. Among authors: de munck l. Lancet Oncol. 2022 Sep;23(9):1201-1210. doi: 10.1016/S1470-2045(22)00482-X. Epub 2022 Aug 8. Lancet Oncol. 2022. PMID: 35952707
BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in HER2-positive breast cancer.
Liefaard MC, van der Voort A, van Ramshorst MS, Sanders J, Vonk S, Horlings HM, Siesling S, de Munck L, van Leeuwen AE, Kleijn M, Mittempergher L, Kuilman MM, Glas AM, Wesseling J, Lips EH, Sonke GS. Liefaard MC, et al. Among authors: de munck l. Breast Cancer Res. 2023 Jun 19;25(1):71. doi: 10.1186/s13058-023-01664-x. Breast Cancer Res. 2023. PMID: 37337299 Free PMC article.
Diagnostics in Patients Suspect for Breast Cancer in The Netherlands.
Voets MM, Groothuis-Oudshoorn CGM, Veneklaas LHJ, Manohar S, Brinkhuis M, Veltman J, de Munck L, de Geus-Oei LF, Broeders MJM, Siesling S. Voets MM, et al. Among authors: de munck l. Curr Oncol. 2021 Nov 29;28(6):4998-5008. doi: 10.3390/curroncol28060419. Curr Oncol. 2021. PMID: 34940058 Free PMC article.
Laparoscopic removal of benign mature teratoma.
Bollen N, Camus M, Tournaye H, De Munck L, Devroey P. Bollen N, et al. Among authors: de munck l. Hum Reprod. 1992 Nov;7(10):1429-32. doi: 10.1093/oxfordjournals.humrep.a137588. Hum Reprod. 1992. PMID: 1291571
Evaluating the Age-Based Recommendations for Long-Term Follow-Up in Breast Cancer.
Witteveen A, de Munck L, Groothuis-Oudshoorn CGM, Sonke GS, Poortmans PM, Boersma LJ, Smidt ML, Vliegen IMH, IJzerman MJ, Siesling S. Witteveen A, et al. Among authors: de munck l. Oncologist. 2020 Sep;25(9):e1330-e1338. doi: 10.1634/theoncologist.2019-0973. Epub 2020 Jun 29. Oncologist. 2020. PMID: 32510767 Free PMC article.
Changes in breast cancer treatment during the COVID-19 pandemic: a Dutch population-based study.
Eijkelboom AH, de Munck L, Menke-van der Houven van Oordt CW, Broeders MJM, van den Bongard DHJG, Strobbe LJA, Mureau MAM, Lobbes MBI, Westenend PJ, Koppert LB, Jager A, Siemerink EJM, Wesseling J, Verkooijen HM, Vrancken Peeters MTFD, Smidt ML, Tjan-Heijnen VCG, Siesling S; NABON-COVID-19 Consortium; COVID and Cancer Care-NL Consortium. Eijkelboom AH, et al. Among authors: de munck l. Breast Cancer Res Treat. 2023 Jan;197(1):161-175. doi: 10.1007/s10549-022-06732-y. Epub 2022 Nov 5. Breast Cancer Res Treat. 2023. PMID: 36334188 Free PMC article.
77 results